233.2K XNYS Volume
XNYS 18 Mar, 2025 11:54 AM (EDT)
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest.
View Similar
Embed DVM
Takeda Pharmaceutical Co -... Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..